Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Orphans Should Live Alone

Feb 18 2016

• By Alain J. Gilbert, Anne Sophie Demange, and Mark Ratner

Related Content

Genentech Reorganization Signals Shift To New Model Under Roche

Apr 20 2009

Repurposing Leptin (Part 2): It Really <em>Is </em>A One-In-A-Million Drug

Dec 20 2013

The Birth Of An Orphan Biosimilar Market

Feb 17 2016

Related Companies

Takeda Pharmaceutical Co. Ltd.

Baxalta Incorporated

Sanofi

Sanofi Genzyme

Pfizer Inc.

GSK plc

BioMarin Pharmaceutical Inc.

Alexion Pharmaceuticals Inc.

Ultragenyx Pharmaceutical Inc.

Alnylam Pharmaceuticals Inc.

NPS Pharmaceuticals, Inc.

Spark Therapeutics, Inc.

Aegerion Pharmaceuticals, Inc.

AstraZeneca PLC

National Institutes of Health

Takeda Pharmaceutical Co. Ltd.

Dyax Corp

ViroPharma Inc.

Roche Holding AG

Genentech, Inc.

Sarepta Therapeutics, Inc.

Additional Topics

Strategy Advertising, Marketing & Sales Launches Deals Approvals BioPharmaceutical

More from Deal-Making

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window